use of elC may surpass use of paper consent forms
Medable partnered with Duke University Department of Population Health Sciences Bioethics and stakeholder (BASE) lab for the pilot study that compared participant comprehension and usability, satisfaction, and preference of enhanced elC versus text-only elC. It specifically explored the use of interactive videos, graphics, calendars, and other tools to augment text in an elC form. The […]
Read More
Pfizer and Arvinas’ jointly develop oral treatment for breast cancer
Vepdegestrant is a novel oral PROteolysis Targeting Chimera (PROTAC) ER degrader specifically for estrogen receptor-positive and HER2-negative metastatic breast cancer previously treated by endocrine-based therapy that is being jointly developed by Arvinas and Pfizer. Being developed jointly by Arvinas and Pfizer, the drug candidate is a heterobifunctional PROTAC (proteolysis-targeting chimera) and selective estrogen receptor degrader (SERD) […]
Read More
Pharmacies in crisis need Charac’s digital help
Thanks to an injection of funds from private equity firm, Traditum, funds raised are now around the £4 million mark following three earlier funding rounds. The company plans to further enhance its online platform for independent pharmacies and accelerate its growth in the UK and internationally. In January, the government and NHS England launched The […]
Read More
New appointments in the pharma industry so far in 2024
Related tags appointments People on the move Pharma industry Jobs Outsourcing Pharma and BioPharma Reporter breaks down the key people on the move in the pharma industry. Enhanc3D Genomics, Cytomos and Cellular Origins are among the companies welcoming new faces to top jobs.
Read More
Rani Therapeutics announces promising phase 1 results for oral Stelara biosimilar
Ustekinumab is a human IgG1қ monoclonal antibody that binds to the p40 protein subunit used by both the interleukin-12 and interleukin-23 (IL-12 and IL-23) cytokines. In the early study with 20 participants, RT-111 was found to be well-tolerated and delivered ustekinumab with high bioavailability. Currently, ustekinumab is available only as a subcutaneous injection (SC) and […]
Read More
Immunic’s CSO – on exploring the fascinating world of viruses
She loves her job and works within a team that believes in the power of diverse perspectives and robust discussions. Read on to discover how she got to where she is today. Could you give us an overview of your work? As chief scientific officer, I oversee the scientific strategy and preclinical development pipeline for […]
Read More
Brainomix 360 platform for stroke care endorsed by NICE
Brainomix 360 (formerly known as e-Stroke) helps clinical decision-making in stroke and was among more than a dozen technologies assessed by NICE, a highly respected health evaluator with a stringent evidence-based approach. Its recommendations carry global significance. The company says the NICE guidance elevates the Brainomix 360 stroke platform, the European market leading solution now […]
Read More
Phesi celebrates 100 million global patient data milestone
The company, a provider of patient-centric data analytics made the announcement today (February 6), that this unparalleled volume of data will allow sponsors to access data on patients with more than 4,000 indications, plan more successful trials, and stimulate clinical development activity with a high degree of accuracy. The company says that with such a […]
Read More
Kinnov Therapeutics alcohol use disorder (AUD) drug progressing well
Historically, the recommended treatment has focused on abstinence and achieving complete sobriety. However, having observed this method’s lack of efficacy, Emmanuel de Rivoire, CEO of Kinnov Therapeutics, (pictured below) has agreed to discuss an alternative treatment strategy with OSP. This new approach, he says, aims to reduce levels of alcohol consumption amongst heavy drinkers, through […]
Read More%20drug%20progressing%20well){kind=link}
finding cancer trial patients like finding needle in haystack
The company recently announced its Omnichannel Network partnership with Massive Bio, a global leader in AI-enabled patient journey mapping platform, to help better connect cancer patients and their oncologists/haematologists to clinical trials. Adamski, senior director of omnichannel solutions, says that because of the difficulty in recruiting for cancer trials the companies are ‘bringing their best and […]
Read More
Lightship at SCOPE 2024 – and its people first approach to trials
Motivated by a commitment to underserved populations, he joined Lightship to prioritize access, choice, and equity in clinical trials, ensuring no group is left behind. Drawing from roles at institutions like UCLA, USC, City of Hope, and Science 37, Sepehr employs novel and innovative strategies to enhance clinical trials. He holds an MPH from the […]
Read More
Lokavant’s trial platform – a game-changer in the industry
He says Lokavant’s solution can provide valuable insights to help streamline your trial process and ensure its success. 1.Why do you think it is important to attend SCOPE? Much like our mission at Lokavant, SCOPE provides every major stakeholder in our industry with an opportunity to connect with other innovators and is the perfect event […]
Read More
AI trend to continue at SCOPE 2024
She has more than 15 years in the life science technology industry significant experience in the investigator grant administration domain having led and provided oversight to the successful technology adoption efforts for clients ranging from top 10 CROs to small and mid-size Sponsor companies. An early clinical career focused on the psycho-social impact of long-term […]
Read More
Repare Therapeutics receives $40 million Roche payment
It earned the milestone payment from Roche for developing and commercializing camonsertib (RP-3500 or RG6526), an oral small molecule drug in Roche’s TAPISTRY trial under its worldwide license collaboration. Tapistry is a phase 2, global, multicenter, open-label, multi-cohort clinical trial designed to evaluate the safety and efficacy of targeted therapies or immunotherapy in participants with […]
Read More
EDETEK platform delivers custom configurable workflows
EDETEK provides clinical technology solutions for the biopharmaceutical, medical devices and CRO companies. The new product forms part of the CONFORM Informatics Platform – Statistical Computing Environment (SCE) which, the company says was built to solve many challenges faced by clinical programmers and statisticians. It features a cloud-native design, modern web-based user interface, ability to […]
Read More
Evaro secures $1.5 million to transform minor healthcare access
Evaro was founded in 2018 by Thuria Wenbar, an emergency doctor and software developer, and her husband, Oskar Wendowski, a pharmacist, after they discovered that 25% of accident and emergency (A&E) consultations and 40% of GP appointments were focused on minor health conditions. The round was led by Cornerstone VC and Exceptional Ventures, with participation from Catalisi’s investment […]
Read More
NeoPhore’s small molecule drugs pipeline gets additional £9.6M
Neophore Limited, a neoantigen immune-oncology company, is generating next-generation, immuno-oncology therapeutics to improve clinical outcomes for cancer patients made the announcement today (February 1). The extension of £9.6 million ($12.2 million) had participation from its existing syndicate, CPF managed by Sixth Element Capital, Claris Ventures, Astellas Venture Management, 3B Future Health Fund, 2investAG, and the […]
Read More
Stevanato bringing advanced biopharmaceutical products to market
The company announced that the two new solutions for efficient small batch pharmaceutical manufacturing – the EZ-fill Kit and the non-GMP laboratory fill and finish service at its Technology Excellence Centers (TEC). The company says when a context where reducing time-to-market is key, its new EZ-fill Kit offers fast access to an adaptable and versatile […]
Read More
GSK drug for enlarged spleen given UK marketing authorisation by MRHA
The drug is for the treatment of disease-related splenomegaly (enlarged spleen) or symptoms in adult patients with moderate to severe anaemia who have primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis and who are Janus kinase (JAK) inhibitor naïve or have been treated with ruxolitinib. Professor Claire Harrison, deputy chief medical officer […]
Read More
Good news for Hong Kong as colorectal cancer treatment approved
The announcement was made today (January 30) that there was marketing approval by the Pharmacy and Poisons Board of Honk Kong for the treatment of adults with previously treated CRC with Elunate. The drug is a selective oral inhibitor of vascular endothelial growth factor (VEGF) receptors -1, -2 and -3, which play a pivotal role […]
Read More
IQVIA: Healthcare data regional compliance complexity requires AI, ML and NLP automation
Always the buzz theme at pharma conferences, the subject of artificial intelligence (AI) continues to crop up more and more frequently. Naturally with more and more people using it for work, new regulations on data use and management are starting to appear.
Read More
Pistoia Alliance flagship project IDMP-O published
The global not-for-profit alliance advocates for ‘greater collaboration in life sciences research and development and now plans to support the implementation of IDMP-O across the pharmaceutical sector. It is now calling for pharma, technology companies, health authorities, and regulators to register interest in dedicated training programs on integrating IDMP-O into workflows. The ontology is already […]
Read More
Curavit at SCOPE 2024 – on seeing green shoots in the industry
The company uses technologies in digital health, cloud computing, and data science to recruit, engage, and monitor diverse patient populations from wherever they live, work, or study taking away the need for travel. Dave Hanaman serves as president and chief commercial officer for Curavit – a company he co-founded he is an operating partner for […]
Read More
SCOPE the place to connect and have meaningful chats
The company provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance and is advancing clinical trials to make them safer, smarter, and faster. Why do you think it is important to attend SCOPE? SCOPE’s size and focus on clinical operations – both best practices today and future innovations […]
Read More
Medable’s hope – driving down the 12-year drug development lifecycle
The company provides an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients, providers & CROs to work together as a team in clinical trials. The company’s vision is to accelerate the path to human discovery and medical cures. Colin Weller, vice president and general manager of Evidence Platform, he […]
Read More
SCOPE 2024 – the top space for collaboration across clinical development
The company’s goal is to help life sciences organizations around the world accelerate clinical development initiatives with expert biometrics services and the elluminate Clinical Data Cloud – the foundation of digital trials. Together, the elluminate platform and eClinical biometrics services aim to give clients self-service access to all their data from one centralized location; plus, […]
Read More
SCOPE 2024 – driving innovation in clinical trials
At the zenith of innovation, OM1 crafts solutions that harness the potential of real-world data and artificial intelligence with solutions like OM1 Aspen and PhenOM. We put some questions to OM1’s Chief Commercial Officer, Shawn Bates in the build-up to SCOPE 2024. Why do you think it is important to attend SCOPE? With uncertainties in […]
Read More
Breye Therapeutics ApS developing oral ophthalmology drugs
Breye Therapeutics ApS announced today (January 25) that the first patient has been dosed in a phase 1b/2a clinical trial to investigate danegaptide, following oral administration, in patients suffering from diabetic macular edema (DMA). The Danish company is a clinical-stage biopharmaceutical company developing new oral therapies for retinal vascular diseases within ophthalmology. Breye is developing […]
Read More
Partnership to enhance efficiency of development for cancer medicine
The two companies aim to develop the next wave of imaging-based diagnostics for precision medicine. Merck is a leading science and technology company that develops next-generation precision medicine technology targeting a wide range of cancers. The two companies are exploring how to harness the potential of biomarkers and radiomics to predict a cancer patient’s response […]
Read More
AI trend to continue at SCOPE 2024
She has more than 15 years in the life science technology industry significant experience in the investigator grant administration domain having led and provided oversight to the successful technology adoption efforts for clients ranging from top 10 CROs to small and mid-size Sponsor companies. An early clinical career focused on the psycho-social impact of long-term […]
Read More
Veeva at SCOPE – primary focus will be driving innovation
We put some questions to him in advance of the summit. What are the current top priorities for the clinical research industry? Artificial intelligence (AI) and automation have become priority areas. However, the technology remains relatively unproven because the outcomes of using AI are still to be determined. Most companies are in the early stages […]
Read More
Colleen Acosta – addressing the unmet needs in women’s health
Could you give us an overview of your work? We have a world class team of leaders in the fields of reproductive health and the microbiome. Freya’s drug candidates comprise full-spectrum microbiota and rationally selected strain consortia, which have the potential to restore an optimal, non-inflammatory vaginal microbiome. Freya announced positive topline data from its […]
Read More
Gerresheimer medical device manufacturer $88 milliion expansion in US
The expansion will create more than 200 new jobs adding to the 260 it already supports there. The German-based company with a plant in Georgia offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems, medical devices, and solutions for the health and cosmetics industry. The existing Gerresheimer manufacturing facility is already in the […]
Read More
Saama platform users now get instant responses to data queries
The company uses AI and advanced analytics to automate key clinical development processes in a bid to accelerate time to market by taking out manual, resource-intensive processes. For the first time, users can ask questions of their data in natural language, and instantly receive responses – eliminating costly data analysis delays. Additionally, data management and […]
Read More
Digital records system gives Priory staff more time to care
The system called Nourish means staff will be released from administrative tasks as the system has enabled the digitisation of the provider’s adult care resident support plans and risk assessments. It has also significantly reduced the use of paper forms it says saves an estimated 84,554 hours a year in staff time. Paul Barnes, chief […]
Read More
Clinical Trial Media launches online portal for studies and trials
The company works with pharmaceutical companies through all stages of clinical research made the announcement earlier this month (January 2024). The new portal enables people to learn how to get involved in the research process and get matched with appropriate studies. Clinical Trial Media says this will help its part in bringing critical therapies and […]
Read More
Luka Yancopoulos, CEO of Grapevine, on data management and supply chains
Luka Yancopoulos is CEO of Grapevine and explains the importance, and challenges, of standardizing data from different sources in order to process it at scale. What are some of the top challenges you see companies facing in implementing data and AI solutions for supply chain visibility? How does Grapevine help address those? Imagine you’ve got a […]
Read More
SGD Pharma’s goal to become market leader in glass packaging
CEO Olivier Rousseau says that SGD Pharma intends to significantly grow in 2024, with a sustained and consistent approach to its strategies. Underpinning this objective Rousseau outlines the investment achievements already notched up in 2023, which he says illustrates how SGD Pharma has paved the way for this planned growth. He said: “The start of 2023 […]
Read More
the importance of federal learning for clinical research
He developed a paper on clinical development to proactively address industry issues earlier this month and OSP put some questions to him in a bid to find out more. In the context of accelerating study startup in clinical research and drug development, the integration of Federated Learning (FL) is highlighted as a pivotal advancement. Could […]
Read More
SmartLabs’ $48 million funding to accelerate scientific development
The company provides flexible laboratory infrastructure and resourcing solutions and welcomed the participation to the funding round from ArrowMark Partners, Winslow Capital Management, and Conversion Venture Capital (CVC2). The company said the Series C financing marks the ‘beginning of the next chapter in the advancement and optimization’ of its laboratory solution portfolio and follows several […]
Read More
Nitisinone brought to rare disease patients thanks to partnership
The partnership, announced today (January 18) will make NITYR (nitisinone) tablets available for eligible patients in the UK with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU). A Free Goods Programme is a compliant way for medicines that are not approved in their country of intended use to be made available for patients who either […]
Read More
GSK’s £200 million investment in the UK and $1.1 billion acquisition
The company formerly known as Glaxosmithkline will put the money towards its sites there until 2025 including constructing new facilities and assembly lines. The company also intends a £67 million revamp of one of its Scottish factories in Montrose with the investment being used to plump up its production of the compounds it uses in […]
Read More
the need for clearly defined regulatory approval
A tour of a mock home with all the technology in place was certainly eye-opening, so we were keen to follow up on their latest vision outlined in a full report. The company says its main aim is to bring the right care to every person, no matter where they are. It uses AI-driven solution […]
Read More
Investment of €10 million for drug delivery company DelSiTech
The financing was co-led by new investors DRW Venture Capital LLC, headquartered in Chicago, and Tolmar International Ltd., based in Dublin, Ireland, which together contributed more than €9 million. The remaining financing was funded by existing DelSiTech shareholders. Lasse Leino, chief executive officer at DelSiTech, said: “We welcome DRW and Tolmar to DelSiTech as new […]
Read More
KBI Biopharma and Argonaut Manufacturing Services form strategic alliance
The companies say the arrangement provides the seamless manufacturing by combining KBI’s leading drug development and biologics manufacturing services with Argonaut’s experience in sterile fill-finish. The alliance reinforces both companies’ commitment to supporting customers in bringing clinical and commercial therapies to patients quickly, safely, and efficiently. KBI and Argonaut say biopharmaceutical organizations are expected to […]
Read More
Cormica Bradford equipment expansion supporting key client programs
The company says it is known for its ‘unwavering commitment to enhancing patient lives through comprehensive testing services’ and that the investment is a strategic step in supporting key client programs. The expansion includes the introduction of two Agilent 1260 Infinity II LCs – described as a robust high-performance liquid chromatography instrument offering a choice […]
Read More
Nutriband Inc. signs fentanyl agreement with Kindeva Drug Delivery
Nutriband Inc., a company that develops transdermal pharmaceutical products has signed a commercial development and clinical supply agreement with its partner, Kindeva Drug Delivery. The agreement is for Nutriband’s lead product Aversa Fentanyl. Under the agreement, CDMO Kindeva, will perform commercial manufacturing process development and manufacture clinical supplies for the human abuse liability clinical study […]
Read More
Medable hopes new technology will cut trial build time by half
The company that provides technology for modern clinical trials says early application of the technology in electronic clinical outcomes assessment (eCOA) deployments – a major delay to study startup industry-wide – is groundbreaking. By automating laborious, manual tasks such as testing, Medable says it saves substantial time and removes eCOA from the critical path to […]
Read More
Gen Li, president and founder of Phesi on data management
Here’s a summary of our question and answer session. How has the role of data management in clinical development changed? The biopharmaceutical industry has adopted new technologies at an unprecedented pace in recent years. Data from patient records, laboratory research and experiments, clinical studies and scientific publications have all been submitted to digital repositories, giving […]
Read More
Picodya’s new technology enables real-time monitoring of human immune status
The company is the creator of the first hybrid in vitro diagnostics (IVD) solution for multiplexed point-of-care testing (xPOCT) and announced the deployment of its B-Matrix technology in National Institutes of Health (NIH) laboratories. Picoyda says this could further the PREMISE (Pandemic REsponse REpository through Microbial and Immune Surveillance and Epidemiology) goal of establishing a […]
Read More
MilliporeSigma and ACD/Labs in collaboration for ChemTwins platform
MilliporeSigma’s first release version of its digital reference material (dRM) ChemisTwin provides scientists in quality control labs with an automated structure verification tool by NMR. NMR is an abbreviation for Nuclear Magnetic Resonance. An NMR instrument allows the molecular structure of a material to be analyzed by observing and measuring the interaction of nuclear spins […]
Read More
Fortrea, Advarra and Veeva form partnership to reduce trial burdens
The partnership aims to deliver an integrated patient- and site-centric solution provoding a smooth and effective clinical trial experience. Fortrea says that because the industry is constantly faced with complex challenges, it wanted to establish an alliance of industry partners, starting with the founding members – Veeva and Advarra, to tackle these challenges head-on. The […]
Read More
Luka Yancopoulos, CEO of Grapevine, on data management and supply chains
Luka Yancopoulos is CEO of Grapevine and explains the importance, and challenges, of standardizing data from different sources in order to process it at scale. What are some of the top challenges you see companies facing in implementing data and AI solutions for supply chain visibility? How does Grapevine help address those? Imagine you’ve got a […]
Read More
WNS on the trials and tribulations of data management
The company says that if business partners are able to harness health date with strong partnerships with the healthcare industry, new use cases will emerge as artifical intelligence (AI) is used correctly and effectively. We put a number of questions to Doctor Gauri Puri who leads the business for life science projects within the healthcare […]
Read More
Hutchmed’s hope for adults with primary immune thrombocytopenia
The company has announced new drug application (NDA) acceptance in China for its small molecule drug, sovleplenib, and it has also been granted priority review by the China National Medical Products Administration (NMPA). The drug being given to patients who have received at least one previous therapy, sovleplenib is a novel, selective, oral inhibitor targeting […]
Read More
Nadège Pelletier from childhood microscope to CSO
OSP: Could you give us an overview of your work? As the CSO, I lead Barinthus Bio’s scientific and technical teams in all phases of drug discovery and early development, from project initiation and platform development, up to clinical PD readouts and manufacturing. This is a very exciting time as we do have a few […]
Read More
Evotec joins forces with the Crohn’s & Colitis Foundation
The foundation is the leading non-profit organization focused on both research and patient support for inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis. Under the collaboration, Evotec joins forces with the foundation’s IBD therapeutics incubator program that facilitates collaboration between the Foundation, academic researchers, and industry partners to translate groundbreaking basic research […]
Read More
New technology could ‘meaningfully impact’ brain trauma
According to the company, its central nervous system (CNS) CAPTON platform improves distribution and proportionate drug activity based on pathology in situ, as well as limiting drug exposure to those areas of the brain suffering pathogenic stress. The chemistry behind the approach involves substituting an essential sulfonate group on suitably configured drugs with an activity-disqualifying […]
Read More
Newron’s evenamide brings good news for patients with CNS diseases
The company, which focuses on the development of therapies for patients with diseases of the central nervous system (CNS) said the ‘never reported before’ results from its open-label study evaluating evenamide. The company reports the data demonstrated that treatment with evenamide was associated with sustained clinically significant benefits that increased throughout the one-year course of […]
Read More
Thermo Fisher’s hope to improve outcomes for ARDS patients
The PPD clinical research business of Thermo Fisher Scientific Inc., a world leader in serving science, has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to implement the first BARDA-supported phase 2 platform clinical trial to investigate multiple therapeutic options for the treatment of ARDS. BARDA is part of the Administration for […]
Read More
ACG joins coveted list of WEF’s Global Lighthouse Network
The company that says it is the largest of its kind, is celebrating the inclusion of its capsule manufacturing facility in Pithampur, India. The WEF’s Global Lighthouse Network (GLN) is a community of manufacturers that shows leadership in using Fourth Industrial Revolution (4IR) technologies to transform factories, value chains and business models, for compelling financial […]
Read More
Thermo Fisher’s hope to improve outcomes for ARDS patients
The PPD clinical research business of science serving world leader Thermo Fisher Scientific Inc., has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to implement the first BARDA-supported phase 2 platform clinical trial that will investigate multiple therapeutic options for the ARDS. BARDA is part of the Administration for Strategic Preparedness and […]
Read More
UK approves treatment for hot flushes during the menopause
“Hot flushes and night sweats caused by menopause are common, and can have a significant impact on a woman’s daily life. We are therefore pleased to have authorised Veoza (fezolinetant) for hot flushes and night sweats caused by menopause via our reliance procedure,” said Julian Beach, interim executive director of healthcare quality and access at […]
Read More
Bristol Myers Squibb buys Karuna Therapeutics for $14 billion
The board of directors at Karuna, a founded entity of PureTech Health, and Bristol Myers Squibb unanimously approved the transaction which also equates to $330 per share. Karuna is a biopharmaceutical company that discovers, develops, and aims to deliver transformative medicines for people living with psychiatric and neurological conditions. Its lead asset, KarXT (xanomeline-trospium), is […]
Read More
Ketamine myths dispelled by clinic following Matthew Perry’s death
Mental health treatment center, the Ketamine Clinics Los Angeles (KCLA) said the storm surrounding the recently announced cause of death for the Friends actor and his reported use of ketamine at the time of his death has prompted its event taking place Friday (January 5) at 1pm PST. Hosted by KCLA co-founders Dr Steven Mandel and Sam […]
Read More
Calliditas IgAN treatment, Tarpeyo, given full FDA approval
IgAN or primary immunoglobulin A neuropathy is an autoimmune disease that occurs when clumps of antibodies are deposited in your kidneys, causing inflammation and kidney damage. Tarpeyo was first approved in December 2021 under accelerated approval, based on the surrogate marker of proteinuria. Marking a significant milestone, it is now the first fully FDA-approved treatment for […]
Read More
Merck launches SaaS platform with 60 billion possibilities
The Aiddison drug discovery software works through Synthia retrosynthesis software application programming interface (API) integration and Merck says it combines generative artificial intelligence (AI), machine learning, and computer-aided drug design to speed up drug development. Trained on more than two decades of experimentally validated datasets from pharmaceutical research and development, Aiddison software identifies compounds from […]
Read More
CellCentric gives hope to last-line multiple myeloma patients
UK-based biotech, CellCentric which spun out of Cambridge University has yesterday (December 11) announced new clinical data for the drug at the American Society for Hematology (ASH) in San Diego. The results follow a recent publication in the Cancer Cell journal, which describes the novel mechanism of action of inobrodib, a first in a new […]
Read More
Neurological diseases focus of Pharmakure’s alliance with Malaysian university
The company will now work with the faculty of pharmacy at Universiti Teknologi MARA (UiTM) with the partnership focused on advancing research initiatives on the use of machine learning tools to predict Alzheimer’s Disease using blood via academic-industry partnerships. Farid Khan, CEO of PharmaKure, (pictured below right) said: “The UK has an aging population, where […]
Read More
HIV pathology data now reaching investigators within hours
Established in 1994 and funded by the National Institutes of Health and National Cancer Institution has opted to use Proscia’s Concentriq for Research, a provider of digital and computational pathology solutions to encourage scientific exploration and discovery in cancer as well as PLWH. The ACSR says its mission is to ‘acquire, store, and equitably distribute […]
Read More
CEO at Vector Laboratories’ instant passion for science
She discovered a passion for science after her very first chemistry lesson and found the subject came easily to her. To find out more about her and how she overcame the challenges of being the first woman scientist in her lab and finding her way in a male-dominated industry. Could you give us an overview […]
Read More
Lindus Health and Thirty Madison’s pilot dermatology study
Treatments for various skin conditions, including atopic dermatitis (eczema), can be sought via the platform through asynchronous evidence-based consultation, patient-reported monitoring, and provider messaging. Using before and after photos of patients, their progress can be monitored. A study by the National Eczema Association in the US revealed that just under 60% of eczema patients are […]
Read More
Atropos Health and SEQESTER partner to speed up drug development
Atropos Health translates real-world clinical date into personalized real-world evidence and insights announced its partnership with SEQESTER today (December 14). Healthcare and life science organizations which use the Atropos Health Evidence Network can establish turnkey patient registries to accelerate evidence generation. This process, the companies say, previously costing millions and requiring up to a year, […]
Read More
Deep Apple’s $52 million funding revolutionizing drug discovery
Deep Apple Therapeutics discovers the therapeutics for high-value targets through virtual screening of artificial intelligence (AI)-generated virtual libraries. With a powerful discovery engine that combines ensemble cryo-EM, deep learning, and molecular docking screens of ultra-large libraries, Deep Apple can go from target identification to lead optimization in less than 12 months – a fraction of […]
Read More
Mission Therapeutics moves kidney disease drug to phase 2 after FDA approval
Up to 160 adults with increased risk for acute kidney injury (AKI) following cardiac surgery are planned to be recruited for the study from multiple sites in North America and Europe. The double-blind, placebo-controlled trial is expected to begin early next year and is intended to show that MTX652 protects this high-risk group of patients […]
Read More
UK approves treatment for hot flushes during the menopause
“Hot flushes and night sweats caused by menopause are common, and can have a significant impact on a woman’s daily life. We are therefore pleased to have authorised Veoza (fezolinetant) for hot flushes and night sweats caused by menopause via our reliance procedure,” said Julian Beach, interim executive director of healthcare quality and access at […]
Read More
New appointments in the pharma industry
Related tags People on the move Pharma industry Jobs Pharmaceutical industry BioPharma Reporter and Outsourcing Pharma presents its latest round-up of the movers, shakers and key announcements in the pharma industry. From Stand Up To Cancer, Astraveus and KBI Biopharma, we break down the key changes.
Read More
Agno Pharma snaps up Particle Sciences to beef up drug product formulation
The acquisition has added Particle Sciences’ specialized drug product formulation technology to the CDMO’s toolkit in addition to the firm’s development and manufacturing site in Bethlehem, Pennsylvania, with approximately 65 employees. The financial details of the deal were undisclosed. Following the takeover, Agno expects to add more capacity to its drug product formulation and clinical […]
Read More
The key pharmaceutical trends from 2023 according to industry leaders
There has been no shortage of excitement over 2023 with a huge number of impactful stories. We have seen big funding rounds investments going into pharmaceutical players, such as a $51 million Series B round raised by the Parkinson’s disease player Cerevance in February and an impressive $210 million round raised in September to power […]
Read More
Five decentralized clinical trial organizations raising big VC cash
As the Covid-19 pandemic raged, lockdowns and strained healthcare systems forced many clinical trials to be delayed or to seek ways to contact patients virtually. However, it was also a catalyst for the adoption of DCTs, which provide a way to bridge this gap. In DCTs, at least some of the trial’s operations take place […]
Read More
FDA approves Arcutis’ skin foam for seborrheic dermatitis
The US Food and Drug Administration (FDA) has approved a topical foam developed by Arcutis Biotherapeutics and branded as Zoryve for the skin condition seborrheic dermatitis in people aged nine years and up.
Read More
‘Motherhood makes me a stronger, more compassionate employee’
We discussed what drew her to the field, her career up to this point, and what she’s excited to see for the next generation of women looking to join the field. BPR: Could you give us an overview of your work? I am the director of eCOA Science at Clario, a leading healthcare research and […]
Read More
Anagenex and Nimbus join forces to develop small molecule treatments using AI
According to the deal terms, Anagenex will generate billions of biochemistry data points for each disease target nominated by Nimbus. Anagenex will then use these data to train AI models that can design 100 million new molecules that bind to the targets, and select the best candidates for developing into drug candidates. The therapeutic areas […]
Read More
FDA approval expands Welireg to patients with renal cell carcinoma
Welireg was originally approved by the FDA in 2021 for a rare genetic condition. The latest approval allows the drug to be used in patients with advanced RCC that have previously received checkpoint inhibitors targeting programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) and blockers of vascular endothelial growth factor tyrosine kinase inhibitor (VEGF-TKI). […]
Read More
Anxiety treated with single dose of psychedelic drug in phase 2b trial
Four weeks after receiving a 100 µg dose of the drug candidate, patients saw a significant reduction in anxiety symptoms compared to a placebo, shown by a 7.6 point drop in the Hamilton Anxiety rating scale (HAM-A). According to the scale, a score lower than 17 signals mild anxiety and 25-30 indicates moderate to severe […]
Read More
Pharma-grade cannabis contracts secured by Celadon
The UK-company is based on the development, production and sale of the medicines and agreed two commercial contracts on May 24 and September 5. The supply of product follows the successful completion of the company’s latest harvest from its UK-based facility, which is being used to fulfil its commercial contracts. Periodic invoicing has now commenced […]
Read More